ID

13020

Beschreibung

Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00083694

Link

https://clinicaltrials.gov/show/NCT00083694

Stichworte

  1. 12.01.16 12.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

12. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT00083694

Eligibility Leukemia NCT00083694

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00083694
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of refractory or relapsed leukemia: acute leukemia, cml, cllm and mds.
Beschreibung

leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C0023418
signed informed consent, including patient agreeing to use safe contraceptive methods during the treatment and for at least 4 months after the treatment is completed
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
serum creatinine < or = 2.5mg/dl
Beschreibung

creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
serum bilirubin< or = 2.5mg/dl
Beschreibung

bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
negative pregnancy test
Beschreibung

pregnancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
age 18 years or older
Beschreibung

age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
performance status < or = 3
Beschreibung

performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating women
Beschreibung

pregnant or lactating women

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
concurrent treatment with cytotoxic chemotherapy, or radiation
Beschreibung

chemotherapy or radiation

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
history of seizures, neurotoxicity, or active cns disease
Beschreibung

seizures, neurotoxicity, or active cns disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0036572
UMLS CUI [2]
C0235032
UMLS CUI [3]
C0007682
serious infections not controlled by antibiotics
Beschreibung

infections

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450

Ähnliche Modelle

Eligibility Leukemia NCT00083694

  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00083694
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
leukemia
Item
diagnosis of refractory or relapsed leukemia: acute leukemia, cml, cllm and mds.
boolean
C0023418 (UMLS CUI [1])
informed consent
Item
signed informed consent, including patient agreeing to use safe contraceptive methods during the treatment and for at least 4 months after the treatment is completed
boolean
C0021430 (UMLS CUI [1])
creatinine
Item
serum creatinine < or = 2.5mg/dl
boolean
C0201976 (UMLS CUI [1])
bilirubin
Item
serum bilirubin< or = 2.5mg/dl
boolean
C1278039 (UMLS CUI [1])
pregnancy
Item
negative pregnancy test
boolean
C0032961 (UMLS CUI [1])
age
Item
age 18 years or older
boolean
C0001779 (UMLS CUI [1])
performance status
Item
performance status < or = 3
boolean
C1518965 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or lactating women
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
chemotherapy or radiation
Item
concurrent treatment with cytotoxic chemotherapy, or radiation
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
seizures, neurotoxicity, or active cns disease
Item
history of seizures, neurotoxicity, or active cns disease
boolean
C0036572 (UMLS CUI [1])
C0235032 (UMLS CUI [2])
C0007682 (UMLS CUI [3])
infections
Item
serious infections not controlled by antibiotics
boolean
C0009450 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video